Glucagon regulates hepatic mitochondrial function and biogenesis through FOXO1

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Glucagon is crucial for maintaining glucose homeostasis, but elevated levels in diabetes contribute to hyperglycemia.
• Mitochondrial dysfunction is a hallmark of diabetes, yet glucagon's direct impact on hepatic mitochondria is unclear.
• FOXO1 (forkhead box protein O1) is a known mediator of glucagon signaling in glucose regulation.

Purpose of the Study:

• To investigate the role of FOXO1 in mediating glucagon's effects on hepatic mitochondrial function.
• To determine how glucagon signaling impacts mitochondrial heme production, respiratory complexes, and biogenesis in the liver.

Main Methods:

• Assessing heme production, mitochondrial complex expression (UQCRC1, MT-CO1), and mitochondrial function in response to glucagon treatment.
• Utilizing hepatocyte-specific Foxo1 gene deletion models.
• Evaluating mitochondrial biogenesis markers (NRF1, TFAM, MFN2) and mitochondrial function in db/db diabetic mice.

Main Results:

• Glucagon decreased heme production and suppressed mitochondrial complexes (UQCRC1, MT-CO1) in a FOXO1-dependent manner.
• Deletion of Foxo1 in hepatocytes largely prevented glucagon-induced suppression of mitochondrial function.
• Glucagon attenuated hepatic mitochondrial biogenesis by reducing NRF1, TFAM, and MFN2 expression, mediated by FOXO1.
• Diabetic db/db mice exhibited suppressed hepatic mitochondrial function and downregulated expression of key mitochondrial proteins.

Conclusions:

• Glucagon negatively regulates hepatic mitochondrial function and biogenesis through a FOXO1-dependent pathway.
• Hyperglucagonemia in diabetes mellitus can lead to impaired liver mitochondrial function, potentially contributing to organ failure.